| Literature DB >> 29255172 |
Eleonora Ingallina1, Giovanni Sorrentino1,2, Rebecca Bertolio1,3, Kamil Lisek1,4, Alessandro Zannini1,3, Luca Azzolin5, Luisa Ulloa Severino3,6, Denis Scaini3,6, Miguel Mano7,8, Fiamma Mantovani1,3, Antonio Rosato9, Silvio Bicciato10, Stefano Piccolo5, Giannino Del Sal11,12.
Abstract
Tumour-associated p53 missense mutants act as driver oncogenes affecting cancer progression, metastatic potential and drug resistance (gain-of-function) 1 . Mutant p53 protein stabilization is a prerequisite for gain-of-function manifestation; however, it does not represent an intrinsic property of p53 mutants, but rather requires secondary events 2 . Moreover, mutant p53 protein levels are often heterogeneous even within the same tumour, raising questions on the mechanisms that control local mutant p53 accumulation in some tumour cells but not in their neighbours 2,3 . By investigating the cellular pathways that induce protection of mutant p53 from ubiquitin-mediated proteolysis, we found that HDAC6/Hsp90-dependent mutant p53 accumulation is sustained by RhoA geranylgeranylation downstream of the mevalonate pathway, as well as by RhoA- and actin-dependent transduction of mechanical inputs, such as the stiffness of the extracellular environment. Our results provide evidence for an unpredicted layer of mutant p53 regulation that relies on metabolic and mechanical cues.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29255172 PMCID: PMC6179142 DOI: 10.1038/s41556-017-0009-8
Source DB: PubMed Journal: Nat Cell Biol ISSN: 1465-7392 Impact factor: 28.824